Marco's Morning Report — Monday, August 31, 2026

Morning, Marco. Munich's last full day was the one aimed squarely at your patients: a blood-pressure trial that moved the needle on dementia, a 91,000-patient answer to "does it matter if they skip doses," and a tricuspid trial with a mean age of 80 and a number-needed-to-treat of four. That's the whole of Section A, and all three are yesterday's news in the literal sense. Then a policy fight whose comment window closes today, and the world got noticeably louder overnight.

A · Top Stories

Trial · Geriatrics

Seven years of tight BP control cut dementia by 15% — and the titration was done by non-physicians

The China Rural Hypertension Control Program reported long-term cognitive outcomes in Hot Line 9 yesterday afternoon in Munich. 326 villages, 33,995 adults (mean age 63, 61% women), cluster-randomized to usual care or a stepped-care protocol run by trained non-physician community health workers targeting SBP <130 / DBP <80. Four active years, then three years of observation only. Systolic fell 17.6 mmHg vs. 2.4 mmHg. At seven years, all-cause dementia was 8.85% vs. 10.55% — adjusted RR 0.85 (95% CI 0.78–0.91, p<0.001) — plus a 13% reduction in cognitive impairment without dementia. Serious adverse events were lower in the intervention arm (47.15% vs. 49.78%). ESC press release.

Why it matters to you: SPRINT MIND hinted at this and never quite closed it. This is a bigger, longer, community-level answer in the same direction, and it lands on the exact population you inherit at 2 a.m. — the 78-year-old whose systolics have run in the 160s for a decade and who now can't tell you what day it is. It also quietly undercuts the assumption that aggressive BP control needs a physician driving. Note the honest limits: rural Chinese cohort, mean age 63 at enrollment, dementia adjudication in a community trial is not the same as a memory-clinic diagnosis.

Talking point: Worth raising the next time someone on your unit reflexively holds home antihypertensives on an elderly admit "to be safe." The framing shifts from "avoid the fall" to "avoid the fall and the seven-year cognitive cost of chronic undertreatment." Neither answer is free.

Meta-analysis · Pharmacotherapy

Antihypertensives only prevented events in patients who actually took them — 91,339 patients, nine trials

The Blood Pressure Lowering Treatment Trialists' Collaboration (Oxford) pooled individual patient data from nine randomized trials and split participants at the 80%-of-doses line. Presented in Munich yesterday morning; presenter Qianqian Yang, University of Oxford. Adherence decayed inside the trials — 88% classified as higher-adherence in year one, 79% by year five. In the higher-adherence group, systolic fell 5.2 mmHg vs. comparator and major cardiovascular disease dropped 11%. In the lower-adherence group, systolic fell only 3.0 mmHg and there was no significant reduction in cardiovascular events at all. ESC press release.

Why it matters to you: Pair this with the CRHCP result above and the message is uncomfortable: the benefit is real and it is entirely contingent. Your admission med rec is where this gets decided. "Lisinopril 20 daily" in the chart is a claim about a prescription, not about a patient. The authors' fixes are the ones you can actually influence at discharge — simplify the regimen, use single-pill combinations, favor longer-acting agents where a missed dose forgives itself.

Suggested action: One extra question at admission — "when did you last take it, not what are you prescribed" — separates uncontrolled hypertension from untreated hypertension. Different discharge plan entirely. ESC's Felix Mahfoud made the same point in the release, framing adherence assessment as routine rather than accusatory.

Trial · Structural / HF

TRIC-I-HF: transcatheter tricuspid repair in 80-year-olds cut death and HF hospitalization, NNT of 4

360 patients with symptomatic severe-or-worse tricuspid regurgitation, all on stable medical therapy, all with either an HF hospitalization in the prior year or cardio-renal / cardio-hepatic syndrome. Mean age 80.3, 56.4% women, 75% NYHA III–IV. Randomized to transcatheter repair plus medical therapy vs. medical therapy alone. Roughly a 60% relative reduction in the combined endpoint of mortality plus HF hospitalization, with early separation of the curves, plus quality-of-life gains. Number needed to treat at one year: four. Presented in a Hot Line yesterday, published simultaneously in NEJM. ESC release · Healio summary.

Why it matters to you: Tricuspid regurgitation has historically been the finding everyone reads off the echo and nobody acts on — "severe TR" filed next to "recommend outpatient follow-up." TRILUMINATE gave quality of life but not hard outcomes, which is why the field called TEER high-tech palliation. This is the first trial to put mortality and hospitalization on the board in exactly your demographic: octogenarian, volume-overloaded, bouncing back with congestive hepatopathy or worsening creatinine. The recurrent-admission phenotype you know well is now potentially a referral, not a disposition problem.

Suggested action: Worth asking your structural heart colleagues where they stand on this before it filters into guidelines — specifically whether your shop has a pathway for TR referral at all, or whether it's still ad hoc.

B · The Debate

Should Medicare pay a hospital outpatient department the same as a doctor's office for the same service?

Why it's live right now: CMS's comment window on the CY 2027 Hospital Outpatient Prospective Payment System proposed rule closes today, August 31. The rule would extend site-neutral pricing to non-contrast imaging performed in grandfathered off-campus hospital outpatient departments, paying the physician-fee-schedule rate instead of the OPPS rate — CMS estimates roughly $260 million out of outpatient spending in CY 2027 alone, on top of a 2.4% net rate increase and a continued phase-out of the inpatient-only list.

The case for site-neutral

Josh Umbehr, MD — family physician, Wichita; Healthcare Dive op-ed, Aug 11, 2026

Medicare currently pays more for an identical service based on the sign over the door, and that price gap is not a payment quirk — it is the acquisition thesis. Systems buy independent practices, re-designate them as provider-based departments, and the same echo or infusion bills at a multiple of what it did the week before, with the patient's coinsurance rising alongside it. MedPAC has recommended equalizing these rates for years on the argument that nothing clinical justifies the difference. Umbehr's case is that Congress should pass the bipartisan Same Care, Lower Cost Act, because paying the same price for the same service simultaneously slows one of Medicare's fastest-growing spending categories, removes the subsidy for consolidation, and lowers what beneficiaries owe — without cutting a single benefit or narrowing access.

The case against

Ashley Thompson — SVP, public policy analysis & development, American Hospital Association; AHA statement on the CY 2027 rule, Jul 2, 2026

Treating a hospital outpatient department as interchangeable with a physician office ignores what the department is actually carrying. HOPD patients are, by Medicare's own data, sicker and more clinically complex, more often disabled, and more often from rural or low-income communities; the department also maintains standby capacity, EMTALA obligations, and 24/7 backup that a freestanding office does not. The AHA's position is that the higher rate is not a windfall but the cross-subsidy that keeps those services open — and that stacking site-neutral expansion on top of an inadequate market-basket update, an aggressive productivity adjustment, and 340B changes lands hardest on exactly the hospitals with the thinnest margins. AHA's fuller argument.

Where it might land: Comments close today; the final rule normally publishes in early November with a January 1 effective date. Congress is separately weighing statutory site-neutral language, so the regulatory outcome is not the last word. Notably, several health system CEOs went on record in the past week signaling openness to a "rational reworking" rather than flat opposition — a softer posture than the trade associations'.

C · On My Radar

Iran — significant escalation overnight. US CENTCOM drone-struck two IRGC launchers on Larak Island in the Strait of Hormuz on Aug 30, the first known strike on Iranian territory in weeks; CENTCOM said the launchers were preparing to fire rockets carrying sea mines into the strait. Iran responded with ballistic missiles at two US bases in Jordan (King Hussein Air Base and al-Azraq); Jordan's military said its air defenses intercepted eight missiles at dawn. Al Jazeera live blog.

Puerto Rico water — decision day. The Comité de Sequía meets today to decide whether to begin rationing for La Plata's ~130,000 customers or expand the existing Carraízo rationing (~183,000). Carraízo sat 0.07 m above the "control" level Sunday morning. AAA said Saturday it does not plan La Plata rationing yet, pending rain from Dolly's remnants. Primera Hora.

Tropics — two things moving. Dolly's remnants (no closed circulation, 20% redevelopment odds over 7 days) bring heavy rain across Puerto Rico today before Hispaniola. More relevant to the Gulf: Invest 97L in the northern Gulf carries 70% development odds at both 48 hours and 7 days, with hurricane hunters scheduled to investigate this morning — Louisiana and the upper Texas coast are the watch areas, no immediate South Florida threat.

COVID — the two dashboards still disagree. CDC's Aug 28 update models infections as growing or likely growing in 48 states, declining in none, yet rates national wastewater activity and COVID ED visits "very low." Texas is "very high," Mississippi "high," Florida "moderate." Stanford's WastewaterSCAN calls national activity "high," with August roughly double July. Rhinovirus/enterovirus rising, which is seasonally normal.

Mets. Astros 6, Mets 3 at Citi Field Aug 30 — LaMonte Wade Jr.'s pinch-hit two-run homer in the sixth was the game. Lindor and Soto went back-to-back to open it (fifth time in franchise history) and Soto homered in his first game back off the IL, but the club finished the homestand 2-4 and is 61-76, last in the NL East. Front-office note: Luis Robert Jr. was placed on outright waivers Aug 29 despite hitting .311/.371/.623 with six homers over his prior 19 games. Vientos went 4-for-5 with three homers on rehab Saturday; Devin Williams resumed throwing.

Cuba. No new mainstream reporting in the last 48 hours. Standing picture from Reuters (Aug 27): the school year opens on schedule tomorrow for ~1.4 million students against a 73% teacher-coverage rate and uniform production meeting about 12% of primary demand, with blackouts at the factories blamed. Six national grid collapses so far in 2026. Expect fresh coverage within 24 hours as schools actually open.

Screens. Coyote vs. Acme — shelved by Warner Bros. as a 2023 tax write-off, bought by Ketchup Entertainment — opened Aug 28 at ~95-96% on Rotten Tomatoes with an A CinemaScore and roughly $14-15M, the distributor's best opening ever. Ridley Scott's The Dog Stars (Elordi, Brolin, Qualley) opened opposite at 37-41%: gorgeous, slow, derivative. Fortune.

D · Trends to Watch

Blood pressure is quietly becoming a neurology intervention. CRHCP joins SPRINT MIND in moving hypertension control out of the pure-cardiovascular column and into dementia prevention. The implication for your admits is that "tight control" stops being a cardiology preference and starts being a cognitive-trajectory decision — with a seven-year horizon that never appears in a three-day hospitalization.

Adherence is being reframed from patient behavior to trial covariate. The BPLTTC analysis shows adherence decaying even inside the controlled environment of a randomized trial. Once the field accepts that treatment effects are conditional on doses actually taken, effectiveness estimates in the real world get revised downward — and the intervention target shifts from the molecule to the regimen's complexity.

Structural intervention keeps migrating into the eighth and ninth decades. TRIC-I-HF's mean age of 80.3 continues the arc from TAVR through mitral TEER to tricuspid. Each step converts a population previously managed with diuretics and expectation-setting into a procedural referral, and each step lands the pre- and post-procedure medical management on hospitalists.

Payment reform is being decided in comment windows, not floor votes. Site-neutral expansion, 340B restructuring, the inpatient-only list phase-out and new prior-auth obligations are all arriving through one OPPS rule whose comment period closes today. The consequential health policy of 2027 is being set administratively while the legislative version stalls.

E · Ideas & Opportunities

Comment on the CY 2027 OPPS rule before the window shuts tonight. This was on the list Aug 26 and today is the deadline. A hospitalist-perspective comment on the imaging site-neutral expansion and the discharge implications of the inpatient-only phase-out is worth more than another trade-association letter.

Add a last-dose question to the admission med rec. Concrete and cheap: for antihypertensives, capture when did you last take this, not just the prescription. The BPLTTC numbers give you the argument if anyone asks why it's worth the extra field.

Post-nights watch: Coyote vs. Acme is genuinely the story of the weekend — 96% and a three-year burial by a studio that wrote it off for taxes. Skip The Dog Stars unless you want cinematography with nothing under it.